© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Breviscapine stands as a natural extract mainly sourced from the plant Erigeron breviscapus. This compound carves out a space for itself in chemistry due to its unique identity and well-documented profile. It is known for its off-white to pale yellow appearance when presented in powder form, offering a crystalline texture that often lands somewhere between flake and powder depending on the refinement process. While not flashy, the product’s physical properties attract attention: Breviscapine melts between 211–215°C and dissolves in common solvents, showing moderate solubility in ethanol or methanol and slightly less so in water.
This compound sits under molecular formula C21H18O10, and the structure reveals a complex arrangement of flavonoid glycosides—primarily scutellarin. Each molecule brings together 21 carbon atoms, 18 hydrogens, and 10 oxygens, building a dense array that leads to a molecular weight of about 430.36 g/mol. The layout of its atoms helps explain its strong performance in certain medical and industrial applications. Scientific analysis confirms a density near 1.67 g/cm³. In raw material form, breviscapine offers reliable purity thanks to rigorous extraction and purification processes, but the product modifications keep the finish consistent across batches.
Manufacturers mostly ship breviscapine as a dry powder or fine flakes, though flakes often indicate a less processed batch. Some specialty suppliers offer breviscapine as pearls or in solution; pearls create less dust and may be safer during transport, while liquid forms provide options for rapid dissolution in laboratories. No matter the form, the solid-state remains most stable for storage and shipping. The appearance matters in the industry, too—clumping, caking, or discoloration can point to poor storage, and best practices in handling avoid humidity and direct light to protect the material’s chemical profile.
Despite plant origins and frequent use in supplement manufacturing, breviscapine isn’t entirely without safety concerns. Inhalation of fine powders can irritate airways; users need proper protective equipment, such as N95 masks and gloves, especially during handling on a production scale. Flammability risk stays low, but chemical incompatibility with strong acids or oxidants calls for prudent segregation in storage. Regarding environmental safety, disposal must respect hazardous material regulations. Industry standards require labeling with the HS Code 29329990, flagging its function as a chemical intermediate. Harmful exposure rarely happens under regular use, but mishandling bulk quantities increases risk. Safe practices draw on real experience: don’t cut corners on ventilation, labeling, or traceability.
Breviscapine takes up residence in multiple sectors: pharmaceuticals, traditional herbal formulations, and biochemical research. Its place as a raw material builds from the defined molecular properties—solubility profiles, stability under light, and minimal moisture attraction. Large-scale producers rely on dense, crystalline breviscapine to simplify blending and dissolving. In solutions, it reaches concentrations around 10 mg/mL, ideal for lab tests or pilot batches in manufacturing. Experience shows that demanding production timelines mean that knowing material density, particle size, and risk factors matters just as much as knowing the molecular structure. Labs, supplement makers, and chemical traders benefit most when the supplier provides not just raw breviscapine but also an up-to-date safety data sheet, robust support, and clear chain-of-custody.
One pressing issue in the breviscapine supply chain lies with the risk of adulteration or variability in botanical raw materials. Actual purity may swing between batches unless tight QA standards monitor plant sourcing, solvent residue, and trace contaminants. Stronger vendor auditing, third-party verification, and batch-level testing break the cycle of guesswork that sometimes plagues plant-derived chemicals. From personal experience, collaboration with regional suppliers in origin areas can dig out quality issues at the farm or primary processing stage, ultimately translating to safer, more reliable final products. Leveraging technology, such as real-time spectrometry, strengthens quality guarantees and improves industry-wide trust.
High density allows for compact packaging and efficient use of storage space, but that benefit only materializes with proper environmental controls. Facilities should target humidity below 50% and temperatures no higher than 25°C for best preservation. Keeping breviscapine away from direct sunlight makes a tangible difference—flavonoids degrade quickly otherwise. Bulk storage tanks lined for corrosion resistance protect against chemical attack, while integrating ventilation shields workers from inhaling airborne particles. In the supply chain, my own work proved that training warehouse staff pays off more than just listing rules on paper. Each person who handles a drum or solution needs to understand the properties of breviscapine as intimately as a chemist does, even if their role is strictly logistics.
Every user of breviscapine, from small biotech start-ups to established pharmaceutical manufacturers, benefits from having honest, specific product details—HS Code, formulas, physical properties, safety data. Overstated claims or vague descriptions can ruin batch outcomes and put downstream health at risk. Detailed spec sheets and on-call technical support build credibility and allow for scaling up with fewer surprises. Ultimately, trust develops one shipment at a time. Transparent communication about risks, such as possible hazardous byproducts or unintended reactions in trial formulas, builds the kind of industry culture that values both profit and public safety. In daily experience, suppliers who take customer questions seriously, update their guidance with new regulatory data, and own responsibility for every kilogram shipped drive better outcomes for everyone in the value chain.
